Human Albumin
Formulation (FDF) · 5g/vial (5%, 100mL); 5g/vial (20%, 25mL); 10g/vial (20%, 50mL); 12.5g/vial (25%, 50mL)
Formulation (FDF)Confidentiality：Public
- INN / Generic Name
- Human Albumin
- Dosage Form
- —
- Strength
- 5g/vial (5%, 100mL); 5g/vial (20%, 25mL); 10g/vial (20%, 50mL); 12.5g/vial (25%, 50mL)
- Therapy Area
- Cardiovascular
- Indication
- Hypovolaemic shock; Intracranial pressure increased; Oedema; Ascites; Hypoproteinaemia; Hyperbilirubinaemia neonatal; Cardiopulmonary bypass; Burn; Haemodialysis; Acute respiratory distress syndrome
- Current Status
- Official FDF licensing catalog (UB133)
- GMP Certification
- CN - NMPA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- Registered (market rights transferable / DCP·NP per market)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
HS Code
3002.15
Registrable Markets
China
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price